team Senior B moves Brienon for 15h
appointment stage at 13:30
appointment stage at 13:30
Senior A team receives Neuvy Sautour for 15h
appointment stadium 14h
appointment stadium 14h
Saturday, March 5, 2011
Thursday, March 3, 2011
How To Get The Combination On Big Nate
Workouts Friday, March 4
Resumed workouts with regular hours:
19H30: Group SG2
21H00: group SG1 (RDV attention Friday to 20.30 for SG1 for a meeting with the coaches)
The girls found the room Duruy. 
Resumed workouts with regular hours:
19H30: Group SG2
21H00: group SG1 (RDV attention Friday to 20.30 for SG1 for a meeting with the coaches)
The girls found the room Duruy.
Honda Team Skierniewice
WE Games 5 and 6 March
Girls are still on vacation.
Two trips for boys:
team 1 plays Saturday night at 8:15 p.m. at Villeneuve de Marsan at the beginning of a series of five games away (4 in the league and cup 1in Landes). This Saturday should allow us to leave in a positive momentum after the failure in France Cup So many serious players will be asked.
The 2 plays a derby on Sunday morning at 11:00 AM in ST PIERRE DU MONT. He must win to avoid falling behind in the standings and keep the chances of catching VIGNAU THE leader of the hen.
The two victories are well within the string of Mons and the aim of the weekend. 
Girls are still on vacation.
Two trips for boys:
team 1 plays Saturday night at 8:15 p.m. at Villeneuve de Marsan at the beginning of a series of five games away (4 in the league and cup 1in Landes). This Saturday should allow us to leave in a positive momentum after the failure in France Cup So many serious players will be asked.
The two victories are well within the string of Mons and the aim of the weekend.
The Symptoms Of The Black Death In Order
When the game is a therapeutic tool
Using video games to deal with emotional conflicts and somatic alterations is not new. By cons, as games like this, serious games, are specially designed to be part of a psychological treatment is much more original, if not unique if more game interacts with the emotions of the patient recorded by sensors.
This innovation was developed in the framework of a European project called PlayMancer which brought together for 3 years from November 2007 to November 2010, eight partners from six different countries including Spain [1]. Each partner has had its role, that of the English partner, Bellvitge Hospital in Barcelona and its units responsible for eating disorders and pathological gambling, was in this case to define the scenarios that the game had to offer to perform its function therapy.
Since last September, the video game is now used regularly validated by the hospital. To its designers, the main objective of this tool original treatment is to teach its users to control their impulses and respond by demonstrating self-control and serenity in the face of stressful situations and frustration, typical manifestations of eating disorders and gambling addiction.
The main objective of the proposed scenario is to get out of an island. The data collected by sensors that detect facial expressions and voice as well as physiological reactions of the patient, can change the course of the game is only coming to check that the patient can "win the game" .
A preliminary study involving 30 patients and 30 control individuals showed that in accordance with the expectations of researchers, patients had improved behavior through play But to definitively proven, it must have been tested longer and more patient. So one solution: "Start again"!
For more information, contact:
[1] Website of the European project PlayMancer: http://www.playmancer.eu/
Source:
- Reference [1]
the brief - the press release dated February 7, 2011 Idibell Foundation Hospital Bellvitge
- La Vanguardia of February 8, 2011 
This innovation was developed in the framework of a European project called PlayMancer which brought together for 3 years from November 2007 to November 2010, eight partners from six different countries including Spain [1]. Each partner has had its role, that of the English partner, Bellvitge Hospital in Barcelona and its units responsible for eating disorders and pathological gambling, was in this case to define the scenarios that the game had to offer to perform its function therapy.
Since last September, the video game is now used regularly validated by the hospital. To its designers, the main objective of this tool original treatment is to teach its users to control their impulses and respond by demonstrating self-control and serenity in the face of stressful situations and frustration, typical manifestations of eating disorders and gambling addiction.
The main objective of the proposed scenario is to get out of an island. The data collected by sensors that detect facial expressions and voice as well as physiological reactions of the patient, can change the course of the game is only coming to check that the patient can "win the game" .
A preliminary study involving 30 patients and 30 control individuals showed that in accordance with the expectations of researchers, patients had improved behavior through play But to definitively proven, it must have been tested longer and more patient. So one solution: "Start again"!
For more information, contact:
[1] Website of the European project PlayMancer: http://www.playmancer.eu/
Source:
- Reference [1]
the brief - the press release dated February 7, 2011 Idibell Foundation Hospital Bellvitge
- La Vanguardia of February 8, 2011
Wednesday, March 2, 2011
Cv Sample Beauticion -
Here are 2 links to a few lines that trace the last Sunday in local newspapers St Yrieix perch.
It speaks of our supporters ...
Cup in France to Villa Handball Sport
http://www.lepopulaire.fr/sports/tous/handball_resultats_de_la_coupe_de_france_departementale_secteur_sud_ouest @ CARGNjFdJSsBExsACh0-.html
Modifying Tundra 2 Skidoo
experimental therapeutic vaccine against AIDS
Nearly 30 years that we have identified suspicious cases of pneumonia in the gay community in San Francisco without a name yet, AIDS began to be talked about.
If since 1996, the cocktails of antiviral drugs have proved successful in reducing to undetectable levels of the virus and have AIDS, at least in Western countries, chronic illness, the hope has long conjured a preventive vaccine, has so far backfired. It's still not a preventive vaccine is talking about a new scientific work, but a therapeutic vaccine which, however, opens interesting perspectives. This is a work primarily directed at Barcelona (13 of 17 researchers, 3 of the 4 others being INSERM-Université Pierre et Marie Curie, Hopital Pitie-Salpetriere in Paris) and involves two clutches AIDS in the Catalan capital, teachers Clotet (IrsiCaixa) and Gatell (Hivacat).
This work appeared in the Journal of Infectious Diseases [1] and available online, reports the results obtained during a Phase I clinical trial on people with HIV: 24 weeks after the first of three injections, vaccinated patients showed an enhanced immune response viral load and three times lower than the control group. This decline which the authors define as modest, has remained at least 48 weeks.
This vaccine is actually a vaccine tailored: from the blood of each patient, researchers have recovered part of the AIDS virus they were inactivated by heating and other dendritic cells (the immune system cells). They then grew the cells in contact with the virus to their "learn" to attack the virus. It is these cells that were injected into each patient. This strategy is not new and is being attempted in other research groups around the world but what is new in this work are the positive results were obtained.
Feasible, safe and well tolerated, to use the adjectives used by researchers in their paper, this strategy is therefore hopeful even though the side "to measure" will always be a limitation. The idea is, if future trials sanctioned the therapeutic approach would be to treat a patient with antivirals and vaccine to maintain without the aid of drugs, viral load very low. This is the meaning of new tests that are ongoing and which researchers believe have results within a year. Continued ...
For more information, contact:
[1] "A Dendritic Cell-Based Therapeutic Vaccine for HIV-1 Infection" by Felipe Garcia et al., Published in J Infect Dis. (2011) 203 [4] 473-478. doi: 10.1093/infdis/jiq077
- The scientific article in question
- El Pais on February 2, 2011
- La Vanguardia of February 2, 2011
Editor: Guy
Molénat, scientific attaché, service. scientifique@sst-bcn.com 
If since 1996, the cocktails of antiviral drugs have proved successful in reducing to undetectable levels of the virus and have AIDS, at least in Western countries, chronic illness, the hope has long conjured a preventive vaccine, has so far backfired. It's still not a preventive vaccine is talking about a new scientific work, but a therapeutic vaccine which, however, opens interesting perspectives. This is a work primarily directed at Barcelona (13 of 17 researchers, 3 of the 4 others being INSERM-Université Pierre et Marie Curie, Hopital Pitie-Salpetriere in Paris) and involves two clutches AIDS in the Catalan capital, teachers Clotet (IrsiCaixa) and Gatell (Hivacat).
This work appeared in the Journal of Infectious Diseases [1] and available online, reports the results obtained during a Phase I clinical trial on people with HIV: 24 weeks after the first of three injections, vaccinated patients showed an enhanced immune response viral load and three times lower than the control group. This decline which the authors define as modest, has remained at least 48 weeks.
This vaccine is actually a vaccine tailored: from the blood of each patient, researchers have recovered part of the AIDS virus they were inactivated by heating and other dendritic cells (the immune system cells). They then grew the cells in contact with the virus to their "learn" to attack the virus. It is these cells that were injected into each patient. This strategy is not new and is being attempted in other research groups around the world but what is new in this work are the positive results were obtained.
Feasible, safe and well tolerated, to use the adjectives used by researchers in their paper, this strategy is therefore hopeful even though the side "to measure" will always be a limitation. The idea is, if future trials sanctioned the therapeutic approach would be to treat a patient with antivirals and vaccine to maintain without the aid of drugs, viral load very low. This is the meaning of new tests that are ongoing and which researchers believe have results within a year. Continued ...
For more information, contact:
[1] "A Dendritic Cell-Based Therapeutic Vaccine for HIV-1 Infection" by Felipe Garcia et al., Published in J Infect Dis. (2011) 203 [4] 473-478. doi: 10.1093/infdis/jiq077
- The scientific article in question
- El Pais on February 2, 2011
- La Vanguardia of February 2, 2011
Editor: Guy
Molénat, scientific attaché, service. scientifique@sst-bcn.com
Cervical Mucus Before Period, Mucus
spontaneous mesosigmoid hematoma: a rare complication of oral anticoagulants throughout
If bleeding GI, induced by anticoagulants are frequent, intramural hematomas and mesenteric are rarer and their topography is preferred proximal duodenum, jejunum and above. The locations colic, especially sigmoid, are exceptional [1].
MSM, 43 years, chronic hemodialysis for five years, carrying a mechanical prosthetic mitral past three years and on long term anticoagulant therapy (Coumadin 4 mg / day) was admitted in March 2005 at the emergency department for pelvic pain lasting for a week, which had worsened, and generalized throughout the abdomen in a few hours with the appearance of syncope.
The examination revealed a state of shock with systolic blood pressure 70 mm Hg and a diastolic of 50 mmHg, profuse sweating, cold extremities and a significant mucocutaneous pallor. Abdominal palpation a tender mass in the left iliac fossa, ill-defined and mobile associated with distention and tenderness of the rest of the abdomen with dullness Slope.
The DRE revealed an melaena. Laboratory tests showed microcytic hypochromic anemia at 6 g / dl of hemoglobin and prothrombin time to 35% with an INR of 2.5. Abdominal ultrasound showed a peritoneal effusion of great abundance and a sigmoid wall thickening with anechoic halo périsigmoïdien.
urgent laparotomy was decided after a brief resuscitation and showed an abundance of hemoperitoneum and a hematoma of the sigmoid cracked and extended to the wall of the sigmoid (Fig. 1). Resection with double stoma was performed (Fig. 2). The postoperative course was uneventful. The restoration of gastrointestinal continuity was performed two months later. Examination histological part of colectomy showed the presence of a hemorrhagic collection at the mesocolon, which was leaking into the colonic subserosa, causing a detachment of the serosa. Elsewhere, there was a very congested in the mucosa and submucosa compared with no other associated injury, particularly vascular.
intramural hematomas can occur throughout the digestive tract. Trauma, hemophilia and anticoagulant therapy are the main causes. Cases of spontaneous hematomas were also reported
[2]. The most common are those located at of the small intestine and duodenum [3,4]. Hematoma of the colon and particularly those induced by anticoagulant therapy are very exceptional. Twelve cases are reported in the literature with only four locations sigmoid [1]. In association with bleeding and intraparietal intramésentérique may appear intraluminal bleeding, intra-or retroperitoneal [4].
abdominal pain and intestinal obstruction in general partial, are common symptoms. The INR is often increased beyond the therapeutic ranges. However, anticoagulants may be responsible intramural hematoma with an INR slightly increased or even normal [1]. Our patient presented without any context traumatic hematoma of the sigmoid mesocolon, associated with intraluminal hemorrhage, intramural and intraperitoneal responsible melaena, with hemoperitoneum, abdominal pain and hemodynamic instability. Oral anticoagulant therapy, although not overdosed, seems to be the cause.
The ground terminal chronic renal insufficiency presented our patient is not associated with coagulopathy, but may nevertheless be responsible for vascular fragility.
diagnosis based on ultrasound, CT and endoscopy [1]. The sonographic appearances of the hematoma are variable in time. Usually the fee is anechoic hematoma. Training and the gradual fragmentation of the clot explain the appearance of internal echoes and the existence of inconsistent type septal structures [5]. The CT appearance of the hematoma also varies over time. Recently, it appears spontaneously hyperdense, becoming isodense and then, finally, hypodense [4]. The management of the hematoma the sigmoid depends on the tolerance of the patient.
Conservative treatment includes aspiration digestive gastric tube in the presence of bowel obstruction, blood transfusion and correction of the state of hypocoagulability by administering low doses of vitamin K and fresh frozen plasma, while avoiding lead hypercoagulability may lead to thrombosis in patients with cardiovascular disease.
However, although most authors advocate conservative treatment in five of the 12 observations cited, surgery was necessary. The surgical approach was motivated by the rupture of the hematoma, abscess formation, abdominal pain and uncontrollable diagnostic uncertainty [1].
mesosigmoid The hematoma induced by anticoagulant during short is exceptional. Its diagnosis is based on ultrasonography and abdominal CT scan. Conservative treatment should be first-line setting. Surgical treatment is reserved for complicated shapes.
References
[1] Trompetas V, Yettimis E, Varsamidakis N, Courcoutsakis N, Kalokairinos E. Endoscopic diagnosis and conservative management of an intramural sigmoid haematoma complicating anticoagulant therapy. Acta Gastroenterol Belg 2007;70:313—5.
[2] Umeda I, Ohta H, Doi T, Nobuoka A, Kanisawa Y, Kawasaki R, et al. Idiopathic intramural hematoma of the colon. Gastrointest Endosc 2007;66:861—4.
[3] Hughes III CE, Conn J, Sherman JO. Intramural hematoma of the gastrointestinal tract. Am J Surg 1977;133:276—9.
[4] Abbas MA, Collins JM, Olden KW, Kelly KA. Spontaneous intramural small-bowel hematoma: clinical presentation and long-term outcome. Arch Surg 2002;137:306—10.
[5] Y Thery, Baumont R, Barkat F. Hematoma of the sigmoid mesocolon. About an exceptional case in Niger. J Radiol 1999; 80:312-6.
H. Chtata
Department of Cardiovascular Surgery, Military Hospital Mohamed V instruction, Rabat, Morocco
A. * Alahyane
Mr. Yaka
Service of Visceral Surgery, Military Hospital Mohamed V instruction, Rabat, Morocco Mr.
Oukabli
Pathology Service, Military Hospital Mohamed V instruction, Rabat , Morocco
Mr. Taberkant
A. Elkirrat
Department of Cardiovascular Surgery, Military Hospital Mohamed V instruction, Rabat, Morocco
* Corresponding author. 3 Department of Surgery, Hospital of Auxerre, 2, boulevard de Verdun, 89000 Auxerre Cedex, France.
E-mail: alahyanew@yahoo.fr
(A. Alahyane).
MSM, 43 years, chronic hemodialysis for five years, carrying a mechanical prosthetic mitral past three years and on long term anticoagulant therapy (Coumadin 4 mg / day) was admitted in March 2005 at the emergency department for pelvic pain lasting for a week, which had worsened, and generalized throughout the abdomen in a few hours with the appearance of syncope.
The examination revealed a state of shock with systolic blood pressure 70 mm Hg and a diastolic of 50 mmHg, profuse sweating, cold extremities and a significant mucocutaneous pallor. Abdominal palpation a tender mass in the left iliac fossa, ill-defined and mobile associated with distention and tenderness of the rest of the abdomen with dullness Slope.
The DRE revealed an melaena. Laboratory tests showed microcytic hypochromic anemia at 6 g / dl of hemoglobin and prothrombin time to 35% with an INR of 2.5. Abdominal ultrasound showed a peritoneal effusion of great abundance and a sigmoid wall thickening with anechoic halo périsigmoïdien.
urgent laparotomy was decided after a brief resuscitation and showed an abundance of hemoperitoneum and a hematoma of the sigmoid cracked and extended to the wall of the sigmoid (Fig. 1). Resection with double stoma was performed (Fig. 2). The postoperative course was uneventful. The restoration of gastrointestinal continuity was performed two months later. Examination histological part of colectomy showed the presence of a hemorrhagic collection at the mesocolon, which was leaking into the colonic subserosa, causing a detachment of the serosa. Elsewhere, there was a very congested in the mucosa and submucosa compared with no other associated injury, particularly vascular.
intramural hematomas can occur throughout the digestive tract. Trauma, hemophilia and anticoagulant therapy are the main causes. Cases of spontaneous hematomas were also reported
[2]. The most common are those located at of the small intestine and duodenum [3,4]. Hematoma of the colon and particularly those induced by anticoagulant therapy are very exceptional. Twelve cases are reported in the literature with only four locations sigmoid [1]. In association with bleeding and intraparietal intramésentérique may appear intraluminal bleeding, intra-or retroperitoneal [4].
abdominal pain and intestinal obstruction in general partial, are common symptoms. The INR is often increased beyond the therapeutic ranges. However, anticoagulants may be responsible intramural hematoma with an INR slightly increased or even normal [1]. Our patient presented without any context traumatic hematoma of the sigmoid mesocolon, associated with intraluminal hemorrhage, intramural and intraperitoneal responsible melaena, with hemoperitoneum, abdominal pain and hemodynamic instability. Oral anticoagulant therapy, although not overdosed, seems to be the cause.
The ground terminal chronic renal insufficiency presented our patient is not associated with coagulopathy, but may nevertheless be responsible for vascular fragility.
diagnosis based on ultrasound, CT and endoscopy [1]. The sonographic appearances of the hematoma are variable in time. Usually the fee is anechoic hematoma. Training and the gradual fragmentation of the clot explain the appearance of internal echoes and the existence of inconsistent type septal structures [5]. The CT appearance of the hematoma also varies over time. Recently, it appears spontaneously hyperdense, becoming isodense and then, finally, hypodense [4]. The management of the hematoma the sigmoid depends on the tolerance of the patient.
Conservative treatment includes aspiration digestive gastric tube in the presence of bowel obstruction, blood transfusion and correction of the state of hypocoagulability by administering low doses of vitamin K and fresh frozen plasma, while avoiding lead hypercoagulability may lead to thrombosis in patients with cardiovascular disease.
However, although most authors advocate conservative treatment in five of the 12 observations cited, surgery was necessary. The surgical approach was motivated by the rupture of the hematoma, abscess formation, abdominal pain and uncontrollable diagnostic uncertainty [1].
mesosigmoid The hematoma induced by anticoagulant during short is exceptional. Its diagnosis is based on ultrasonography and abdominal CT scan. Conservative treatment should be first-line setting. Surgical treatment is reserved for complicated shapes.
References
[1] Trompetas V, Yettimis E, Varsamidakis N, Courcoutsakis N, Kalokairinos E. Endoscopic diagnosis and conservative management of an intramural sigmoid haematoma complicating anticoagulant therapy. Acta Gastroenterol Belg 2007;70:313—5.
[2] Umeda I, Ohta H, Doi T, Nobuoka A, Kanisawa Y, Kawasaki R, et al. Idiopathic intramural hematoma of the colon. Gastrointest Endosc 2007;66:861—4.
[3] Hughes III CE, Conn J, Sherman JO. Intramural hematoma of the gastrointestinal tract. Am J Surg 1977;133:276—9.
[4] Abbas MA, Collins JM, Olden KW, Kelly KA. Spontaneous intramural small-bowel hematoma: clinical presentation and long-term outcome. Arch Surg 2002;137:306—10.
[5] Y Thery, Baumont R, Barkat F. Hematoma of the sigmoid mesocolon. About an exceptional case in Niger. J Radiol 1999; 80:312-6.
H. Chtata
Department of Cardiovascular Surgery, Military Hospital Mohamed V instruction, Rabat, Morocco
A. * Alahyane
Mr. Yaka
Service of Visceral Surgery, Military Hospital Mohamed V instruction, Rabat, Morocco Mr.
Oukabli
Pathology Service, Military Hospital Mohamed V instruction, Rabat , Morocco
Mr. Taberkant
A. Elkirrat
Department of Cardiovascular Surgery, Military Hospital Mohamed V instruction, Rabat, Morocco
* Corresponding author. 3 Department of Surgery, Hospital of Auxerre, 2, boulevard de Verdun, 89000 Auxerre Cedex, France.
E-mail: alahyanew@yahoo.fr
(A. Alahyane).
Subscribe to:
Posts (Atom)